Indefinite Delivery Contract 36C24226D0045
- Not listed
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Eurofins Transplant Genomics, LLC. The contract, valued at up to $7,500,000, is for reference laboratory testing services to support the VA Portland Healthcare System's kidney transplant program in the Western Region. The primary purpose of the contract is to provide a non-invasive blood test, known as donor-derived cell-free DNA (dd-cfDNA) testing, to...
- This indefinite delivery contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VA VISN 2) to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, to deliver a full range of integrated oncology esoteric testing services. The contract has a total ceiling value of $4,696,984.10 and a period of performance from July 1, 2020 through June 30, 2025. The contracted services include the transportation of clinical laboratory...
- The federal contract IDV award is for LAB TESTS FOR POST TRANSPLANT CARE, issued by the Department of Veterans Affairs (VA) to the prime contractor Caredx, Inc., a for-profit medical diagnostics company based in Brisbane, California. This is a single-award Indefinite Delivery Contract valued at $4,367,680.42 with a period of performance from April 1, 2025 to March 31, 2030. The contract aims to procure a range of specialized genetic and molecular testing services from Caredx, including the...
- The Veterans Integrated Service Network 2 (VA-VHA VISN 2), a civilian agency within the U.S. Department of Veterans Affairs, awarded a single-award Indefinite Delivery Contract valued at $1,235,165 to The Rogosin Institute Inc., a non-profit organization specializing in renal disease research and clinical services based in New York City. The contract, awarded on December 3, 2020, with an ultimate completion date of May 31, 2026, procures tissue typing and immunogenetics testing services to...
- Quest Diagnostics Incorporated has been awarded a single-award Blanket Purchase Agreement by Veterans Integrated Service Network 2 (VISN 2), a component of the Department of Veterans Affairs, with a ceiling value of $655,178.76 under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract, awarded July 1, 2025, with an ultimate completion date of June 30, 2026, establishes a firm fixed-price vehicle for providing specialized genetic and esoteric...
- This federal Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 16, a civilian agency under the Department of Veterans Affairs (VA), to Preventiongenetics LLC, a for-profit limited liability company specializing in advanced genetic testing services. The contract has a ceiling value of $1,719,533.16 and a period of performance through June 1, 2030. The primary purpose of this IDC is to provide TESTING SERVICES FOR LAB SAMPLES to support the VA's healthcare...
- This is a single award, firm-fixed price, indefinite delivery, indefinite quantity (IDIQ) contract awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) to Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract has a ceiling value of $2,125,000 and a period of performance from June 1, 2021 through May 31, 2026, with an optional 6-month extension. The contract aims to provide VISN 17 with on-demand access to a...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a single award indefinite-delivery/indefinite-quantity contract to Life Technologies Corporation with a potential value of $400,000.00 and a period of performance through September 2026. Two firm fixed price delivery orders have been issued against this contract to date for tissue typing kits and related services. Delivery Order OP1, valued at $59,928, has a completion date of...
- Quest Diagnostics Incorporated, a leading clinical laboratory testing company headquartered in Secaucus, New Jersey, was awarded a single-award Blanket Purchase Agreement by Veterans Integrated Service Network 17 (VISN 17), a civilian component of the Department of Veterans Affairs, effective March 1, 2026 through February 28, 2031. The contract carries a ceiling value of $5.5 million and is structured as a firm fixed-price vehicle under the Medical Laboratory Testing and Analysis Services...
- The Department of Veterans Affairs (VA) has awarded a single-award indefinite delivery contract (IDC) to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., for the provision of CAREDX ALLOMAP molecular testing services. The $787,000 IDC, which runs through June 2027, enables Caredx to be the sole provider of the FDA-approved AlloMap test within the VA's Veterans Integrated Service Network 17 (VISN 17). This specialized test aids in post-transplant surveillance and patient management for...
- 36C24226D0045Indefinite Delivery Contract
- 1Federal Contract Awards
The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2), awarded a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Eurofins Transplant Genomics, LLC (UEI: QGB2L5JWUQF9) for donor-derived cell-free DNA (DD-cfDNA) testing services supporting the James J. Peters VA Medical Center's Renal Transplant Program. The contract, issued April 1, 2026, establishes a five-year ordering period through March 31, 2031, with a ceiling value of $600,000 and no set-aside designation applied. The prime contractor must deliver CLIA-certified and CAP-accredited laboratory services including specimen collection kits, secure courier transport with 48-hour delivery, testing analysis with 72-hour results turnaround, staff training, and clinical interpretation support. Services are performed in Bronx, New York, and the contract structure accommodates estimated annual test volumes of 30 to 45 tests distributed across four line items. DD-cfDNA testing represents a specialized molecular diagnostic procedure critical to post-transplant surveillance, enabling detection of donor-derived genetic material in kidney transplant recipients to assess graft health and identify early indicators of organ rejection. The initial delivery order issued under this IDIQ vehicle on April 1, 2026, carries a firm fixed-price ceiling value of $41,250 with a completion date of March 31, 2027, providing baseline testing services to establish operational capabilities. The solicitation (RFQ 36C24226Q0287), posted February 6, 2026, with a response deadline of February 20, 2026, required contractors to demonstrate technical capability, provide relevant past performance documentation from the preceding three years, and submit competitive pricing. All service providers must maintain current federal and state laboratory licenses, comply with HIPAA and VA information security requirements, adhere to DOT/IATA biological specimen transport regulations, and employ qualified personnel with appropriate training and proficiency testing credentials. The contracting office, administered by the Samuel S. Stratton VA Medical Center in Albany, New York, evaluated proposals based on technical merit, past performance quality and recency, and price reasonableness, with contracting officer Mariangie Rivera overseeing administration of the procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/31/26 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C24226D0045-36C24226N0421 | Eurofins Transplant Genomics, LLC | $41.3k | 4/1/26 | 3/31/27 | 3/31/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--DONOR-DERIVED CELL FREE DNA TESTING KITS | 36C24226Q0287 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Solicitation 1/2 | 2/6/26, 1:20 PM | |
Q301--DONOR-DERIVED CELL FREE DNA TESTING | 36C24226Q0287 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Award Notice 2/2 | 4/1/26, 4:41 PM |